High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.


Autoria(s): Stupp R.; Tonn J.C.; Brada M.; Pentheroudakis G.; ESMO Guidelines Working Group
Data(s)

2010

Identificador

http://serval.unil.ch/?id=serval:BIB_9D88B4C208E4

isbn:1569-8041[electronic], 0923-7534[linking]

pmid:20555079

doi:10.1093/annonc/mdq187

isiid:000278968900040

Idioma(s)

en

Fonte

Annals of Oncology, vol. 21, no. Suppl 5, pp. 190-193

Palavras-Chave #Phase-III Trial; Mgmt Promoter Methylation; European-Organization; Glioblastoma-Multiforme; Recurrent Glioblastoma; Adjuvant Temozolomide; Radiation-Therapy; Tumor; Radiotherapy; Chemotherapy
Tipo

info:eu-repo/semantics/review

article